Branched chain amino acid treatment of tardive dyskinesia in children and adolescents.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Clinical Psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4088/JCP.V65N0116PMID 14744176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intra-patient variability in the measurement of tardive dyskinesia

  2004cited by this paper
• Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.

  2003cited by this paper
• Atypical antipsychotic drugs and hyperglycemia in adolescents.

  2001cited by this paper
• Hyperglycemia associated with the use of atypical antipsychotics.

  2001cited by this paper
• Neuroleptic-related dyskinesias in children and adolescents.

  2001cited by this paper
• Estrogen for bone health in frail elderly women.

  2001cited by this paper
• Risperidone for the treatment of stuttering.

  2000cited by this paper
• Establishing a standard definition for child overweight and obesity worldwide: international survey

  2000cited by this paper
• Branched chain amino acids decrease tardive dyskinesia symptoms

  1999cited by this paper
• Phenylalanine kinetics are associated with tardive dyskinesia in men but not in women

  1999cited by this paper
• Use of Neuroleptics in Children

  1999cited by this paper
• Case series: spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia.

  1998cited by this paper
• Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study.

  1997cited by this paper
• Increased dopamine activity associated with stuttering

  1997cited by this paper
• Psychopharmacology in Child and Adolescent Psychiatry: A Review of the Past Five Years

  1995cited by this paper
• [Effect of the age and the sex on plasma concentration of amino acids].

  1994cited by this paper
• Effect of branched-chain amino acid supplementation on the exercise-induced change in aromatic amino acid concentration in human muscle.

  1992cited by this paper
• Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.

  1991cited by this paper
• Valine, isoleucine, and leucine. A new treatment for phenylketonuria.

  1990cited by this paper
• The plasma phenylalanine/large neutral amino acid ratio: a risk factor for tardive dyskinesia.

  1989cited by this paper
• Pharmacotherapy of affective disorders in children and adolescents.

  1989cited by this paper
• Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children.

  1989cited by this paper
• Psychopharmacology in child and adolescent psychiatry: a review of the past five years.

  1988cited by this paper
• Branched Chain Amino and Keto Acids in Health and Disease

  1986cited by this paper
• Plasma free amino acid values in normal children and adolescents.

  1986cited by this paper
• The prevalence of tardive dyskinesia in a mentally retarded population.

  1986cited by this paper
• Prevalence of tardive dyskinesia in elderly samples.

  1984cited by this paper
• Branched-chain amino acid metabolism.

  1984cited by this paper
• Branched chain amino and keto acids as regulators of insulin and glucagon release.

  1984cited by this paper
• Neuroleptic-induced dyskinesias in children.

  1983cited by this paper
• The coexistence of parkinsonism-like symptoms and tardive dyskinesia.

  1982cited by this paper
• Reduction of Cerebrospinal Fluid Phenylalanine after Oral Administration of Valine, Isoleucine, and Leucine

  1982cited by this paper
• A rating scale for tardive dyskinesia

  1979cited by this paper
• Factors affecting plasma amino acid concentrations in control subjects.

  1979cited by this paper

• Head Injury Treatment With Healthy and Advanced Dietary Supplements: A Pilot Randomized Controlled Trial of the Tolerability, Safety, and Efficacy of Branched Chain Amino Acids in the Treatment of Concussion in Adolescents and Young Adults

  2024cites this paper
• Tardive Dyskinesia with Antipsychotic Medication in Children and Adolescents: A Systematic Literature Review

  2024cites this paper
• Pathophysiology, prognosis and treatment of tardive dyskinesia

  2022cites this paper
• A unifying theory for the pathoetiologic mechanism of tardive dyskinesia.

  2020cites this paper
• Food supplements - High intake of isolated branched-chain amino acids can lead to health impairments

  2020cites this paper
• Antipsychotic-Induced Neurological Adverse Events

  2019cites this paper
• Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials

  2018cites this paper
• Branched-Chain Amino Acids Enhance Retinal Ganglion Cell Survival and Axon Regeneration after Optic Nerve Transection in Rats

  2018cites this paper
• Non-VMAT2 inhibitor treatments for the treatment of tardive dyskinesia.

  2018cites this paper
• Medication-Induced Tardive Dyskinesia: A Review and Update.

  2017cites this paper
• Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients

  2017cites this paper
• Tardive Dyskinesia: 21st Century May Bring New Treatments to a Forgotten Disorder

  2017cites this paper
• Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia

  2016cites this paper
• Metabolism of BCAAs

  2015cites this paper
• Tardive dyskinesia (syndrome): Current concept and modern approaches to its management

  2015cites this paper
• Tardive Dyskinesia: Therapeutic Options for an Increasingly Common Disorder

  2013cites this paper
• New and emerging treatments for symptomatic tardive dyskinesia

  2013cites this paper
• Treatment of tardive dyskinesia: a systematic review (1997-2011)

  2013cites this paper
• [Not Available].

  2012cites this paper
• Les recommandations thérapeutiques relatives aux effets secondaires extrapyramidaux associés à l’utilisation d’antipsychotiques de deuxième génération chez les enfants et les adolescents

  2012cites this paper
• Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth.

  2011cites this paper
• Drug therapies for tardive dyskinesia: part 2.

  2011cites this paper
• AN OVERVIEW OF TARDIVE DYSKINESIA

  2010cites this paper
• Dietary branched chain amino acids ameliorate injury-induced cognitive impairment

  2009cites this paper
• Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia and Other Disorders

  2007cites this paper
• Drug-induced movement disorders in children and adolescents

  2005cites this paper
• La alimentación en las enfermedades del espectro esquizofrénico.

  2004cites this paper
• The Journal of Interventions in Clinical Practice Tardive Dyskinesia in Patients Treated with Atypical Antipsychotics: Case Series and Brief Review of Etiologic and Treatment Considerations

  year unknowncites this paper